Tel. +41 44 980 8000
info@strategicswisspartners.com
Churerstrasse 20, 8808 Pfäffikon, Switzerland

Global Chinese Economic & Technology Summit: Technology connecting countries to benefit all

by David, Weige. SSP Executive Partner Marketing & PR   Penang, Malaysia – 16. December 2021 As the world recovers from the global pandemic, government, business and academic leaders from Malaysia, China, other Asia Pacific countries and Switzerland came together at the Global Chinese Economic & Technology Summit (GCETS) to share ideas about how to […]

Shanghai aims to become one of the top global hubs for asset management by 2025.

Expansion in QFLP schemes will open doors to assets in private markets for local and foreign investors. Shanghai, China, 1 September 2021 Shanghai is dedicated to open up further two-way financial investments with multiple measures like promoting the Qualified Foreign Limited Partner (QFLP) and Qualified Domestic Limited Partner (QDLP) pilot programs, in an effort to […]

SSP LAUNCHES SSP SPORTS

Zurich, Switzerland, 14 July 2021 Strategic Swiss Partners (SSP) is pleased to announce the launch of SSP Sports. Pioneering partnerships and creating new possibilities, it is in our veins. Our track record of building credible and genuine partnerships speaks for itself. SSP’s new business unit strengthens its focus on sports, including e-sports, related acquisition of […]

SSP signs Partnership Agreement with Shanghai Guo’ang Industrial-China State Cloud Fund

Shanghai, China, 1 July 2021 On the evening of June 25, the signing ceremony for cooperation between Jinan municipal government and Zhongqi Guoyun Energy Technology Co., Ltd. (“Zhongqi Guoyun”), Singapore SUNSEAP, Guoang Industrial, and Strategic Swiss Partners (SSP) was held in Long’ao Building. Licheng Sun, member of the Standing Committee of the Provincial Party Committee […]

STOP CORONA… ALREADY IN THE NOSE!

Interview with the Head of Research and Development, Dr. Claudia Mattern, PhD, adj. Professor Chief Science Officer MetP Pharma AG Action (Protection) instead of Reaction in viral airway invasion. Emmetten, Switzerland, 28 January 2021 MetP Pharma AG is a R&D company focused exclusively on nasal application; whose technology represents a real advance in the application […]

MetP Pharma’s Nascum-VIREX will be evaluated for its protective effect against viral infection.

The results of the study are expected by first quarter 2021. Emmetten, Switzerland, 1 November 2020 MetP® Pharma AG recently announced that its nasal gel Nascum®-VIREX will be evaluated for its protective effect against viral infection. The aim of the study is to test the effect of acute dose apical exposure of Nascum®-VIREX upon viral […]

1 2 3 4 5 8